Bohemine is primarily utilized in research settings as a potent and selective inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK5. Its ability to inhibit these kinases makes it a valuable tool in studying cell cycle regulation and the mechanisms of cellular proliferation. Researchers often employ Bohemine to investigate its effects on cancer cells, as CDK inhibition can lead to cell cycle arrest and apoptosis, providing insights into potential cancer therapies. Additionally, it is used in studies exploring neurodegenerative diseases, where CDK5 dysregulation is implicated. Bohemine's role in these areas helps advance understanding of disease pathways and supports the development of targeted therapeutic strategies.